Thymosin Alpha-1 99% White powder..

Thymosin alpha 1 α 1 ) is a peptide that treats chronic hepatitis B and enhances immune system responsiveness. thymus increases the secretion of interfer by T cells after antigen or mitogen activation α, interfer γ And the levels of lymphokines such as interleukin-2 and interleukin-3, while increasing the level of lymphokine receptors on the surface of T cells. It is also possible to enhance the mixed lymphocyte response of allogeneic and autologous humans by activating CD4 cells. Thymic peptide α 1 may increase the aggregation of pre NK cells, while interfer can enhance their cytotoxicity. In vivo experiments have shown that thymosin alpha1 can increase the expression level of interleukin-2 receptors in mouse lymphocytes activated by concanavalin A, while also increasing the secretion level of interleukin-2. Current thymic peptides on the market α The synthesis preparation method has a long synthesis cycle and high production cost, which is not conducive to the large-scale production of bivaludine.

1. Expertise in Peptide Synthesis

Extensive Experience: 7 Years of expertise in synthetic peptide development.

Skilled Team: Experts in solid-phase and liquid-phase synthesis.

2. Advanced Manufacturing Capabilities

Cutting-Edge Facilities: High-precision equipment ensuring purity and bioactivity.

Scalable Production: From milligram-scale research peptides to multi-kilogram industrial batches.

3. Innovation & Customer Commitment

Reliable Supply Chain: Competitive pricing & timely global delivery.

Global Reach: Trusted by researchers, pharmaceutical firms & industrial clients worldwide.

 Who We Serve

-We proudly work with clients across North America, Europe, Asia, and Latin America, including:

-Biotech and pharma firms

-Research institutions & universities

-Peptide formulation startups

-CDMOs and CRO partners